| Literature DB >> 12002810 |
Masatsugu Ohtsuki1, Hiroaki Shiraishi, Taiya Kato, Risa Kuroda, Masahiro Tazawa, Chiho Sumi-Ichinose, Shin Tada, Yasutoshi Udagawa, Mitsuyasu Itoh, Hitoshi Hishida, Hiroshi Ichinose, Toshiharu Nagatsu, Yasumichi Hagino, Takahide Nomura.
Abstract
We studied the effects of cAMP on cytokine (interferon-gamma plus tumor necrosis factor-alpha)-induced stimulation of tetrahydrobiopterin (BH4) synthesis in human umbilical vein endothelial cells (HUVEC). The cytokine mixture caused a marked increase in the biosynthesis and release of BH4 by HUVEC. Dibutyryl-cAMP produced a dose-dependent inhibition of this cytokine-induced stimulation of synthesis and release of BH4 by these cells. 8-Bromo-cAMP also caused a significant inhibition, although the effects were less marked than those of dibutyryl-cAMP. Both forskolin and the stable analog of prostacyclin, iloprost, caused cAMP accumulation and a concomitant diminution of the cytokine-induced BH4 synthesis in HUVEC. Dibutyryl-cAMP and iloprost also significantly inhibited the cytokine-induced stimulation of GTP cyclohydrolase I (GCHI) activity and mRNA production. We concluded that the suppression by the cAMP messenger system of cytokine-induced stimulation of synthesis and release of BH4 by HUVEC can be attributed to the inhibition of the activity of GCHI, the rate-limiting enzyme in BH4 biosynthetic pathway, in HUVEC. The data also suggest that the cAMP-mediated reduction in the GCHI mRNA level may at least partially explain the decline in GCHI activity. It is reasoned that under inflammatory conditions, cAMP-elevating agents such as prostacyclin exert regulatory effects on circulation by inhibiting cytokine-induced synthesis and release of BH4 by HUVEC.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12002810 DOI: 10.1016/s0024-3205(02)01503-5
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037